Literature DB >> 33113036

Destructive Roles of Fibroblast-like Synoviocytes in Chronic Inflammation and Joint Damage in Rheumatoid Arthritis.

Maryam Masoumi1, Hamidreza Bashiri2, Hossein Khorramdelazad3,4,5, Khadijeh Barzaman3, Nader Hashemi6, Hale Abdoli Sereshki3, Amirhossein Sahebkar7,8,9, Jafar Karami10,11.   

Abstract

Fibroblast-like synoviocytes (FLSs) are important non-immune cells located mostly in the inner layer of the synovium. Indeed, these cells are specialized mesenchymal cells, implicated in collagen homeostasis of the articular joint and provide extracellular matrix (ECM) materials for cartilage and contribute to joint destruction via multiple mechanisms. RA FLS interactions with immune and non-immune cells lead to the development and organization of tertiary structures such as ectopic lymphoid-like structures (ELSs), tertiary lymphoid organs (TLOs), and secretion of proinflammatory cytokines. The interaction of RA FLS cells with immune and non-immune cells leads to stimulation and activation of effector immune cells. Pathological role of RA FLS cells has been reported for many years, while molecular and cellular mechanisms are not completely understood yet. In this review, we tried to summarize the latest findings about the role of FLS cells in ELS formation, joint destruction, interactions with immune and non-immune cells, as well as potential therapeutic options in rheumatoid arthritis (RA) treatment. Our study revealed data about interactions between RA FLS and immune/non-immune cells as well as the role of RA FLS cells in joint damage, ELS formation, and neoangiogenesis, which provide useful information for developing new approaches for RA treatment.

Entities:  

Keywords:  Immune and non-immune cells; ectopic lymphoid-like structures (ELSs); fibroblast-like synoviocytes (FLSs); rheumatoid arthritis (RA)

Mesh:

Substances:

Year:  2020        PMID: 33113036     DOI: 10.1007/s10753-020-01371-1

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  88 in total

1.  Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.

Authors:  Natalia Wegner; Robin Wait; Aneta Sroka; Sigrun Eick; Ky-Anh Nguyen; Karin Lundberg; Andrew Kinloch; Shauna Culshaw; Jan Potempa; Patrick J Venables
Journal:  Arthritis Rheum       Date:  2010-09

Review 2.  Epigenetics in rheumatoid arthritis; fibroblast-like synoviocytes as an emerging paradigm in the pathogenesis of the disease.

Authors:  Jafar Karami; Saeed Aslani; Mohammad Naghi Tahmasebi; Mohammad Javad Mousavi; Arash Sharafat Vaziri; Ahmadreza Jamshidi; Elham Farhadi; Mahdi Mahmoudi
Journal:  Immunol Cell Biol       Date:  2020-01-26       Impact factor: 5.126

Review 3.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

Review 4.  Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review.

Authors:  Jafar Karami; Saeed Aslani; Ahmadreza Jamshidi; Masoud Garshasbi; Mahdi Mahmoudi
Journal:  Gene       Date:  2019-03-20       Impact factor: 3.688

5.  BLyS and APRIL in rheumatoid arthritis.

Authors:  Thorsten M Seyler; Yong W Park; Seisuke Takemura; Richard J Bram; Paul J Kurtin; Jörg J Goronzy; Cornelia M Weyand
Journal:  J Clin Invest       Date:  2005-10-20       Impact factor: 14.808

6.  Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

Authors:  Solbritt Rantapää-Dahlqvist; Ben A W de Jong; Ewa Berglin; Göran Hallmans; Göran Wadell; Hans Stenlund; Ulf Sundin; Walther J van Venrooij
Journal:  Arthritis Rheum       Date:  2003-10

7.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.

Authors:  C Turesson; W M O'Fallon; C S Crowson; S E Gabriel; E L Matteson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

8.  Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis.

Authors:  Hiba Mahdi; Benjamin A Fisher; Henrik Källberg; Darren Plant; Vivianne Malmström; Johan Rönnelid; Peter Charles; Bo Ding; Lars Alfredsson; Leonid Padyukov; Deborah P M Symmons; Patrick J Venables; Lars Klareskog; Karin Lundberg
Journal:  Nat Genet       Date:  2009-11-08       Impact factor: 38.330

Review 9.  Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.

Authors:  Kevin D Deane; Hani El-Gabalawy
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

Review 10.  Ectopic lymphoid-like structures in infection, cancer and autoimmunity.

Authors:  Costantino Pitzalis; Gareth W Jones; Michele Bombardieri; Simon A Jones
Journal:  Nat Rev Immunol       Date:  2014-06-20       Impact factor: 53.106

View more
  10 in total

Review 1.  Role of T Cells in the Pathogenesis of Rheumatoid Arthritis: Focus on Immunometabolism Dysfunctions.

Authors:  Maryam Masoumi; Samira Alesaeidi; Hossein Khorramdelazad; Mousa Behzadi; Rasoul Baharlou; Shahin Alizadeh-Fanalou; Jafar Karami
Journal:  Inflammation       Date:  2022-10-10       Impact factor: 4.657

Review 2.  Medical Cannabis Activity Against Inflammation: Active Compounds and Modes of Action.

Authors:  Seegehalli M Anil; Hadar Peeri; Hinanit Koltai
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

3.  Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6.

Authors:  Piero Ruscitti; Vasiliki Liakouli; Noemi Panzera; Adriano Angelucci; Onorina Berardicurti; Elena Di Nino; Luca Navarini; Marta Vomero; Francesco Ursini; Daniele Mauro; Vincenza Dolo; Francesco Ciccia; Roberto Giacomelli; Paola Cipriani
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-18

4.  Transcriptional Regulation of CD40 Expression by 4 Ribosomal Proteins via a Functional SNP on a Disease-Associated CD40 Locus.

Authors:  Meijuan Zou; Xiaoyu Zhang; Danli Jiang; Yihan Zhao; Ting Wu; Qiaoke Gong; Hang Su; Di Wu; Larry Moreland; Gang Li
Journal:  Genes (Basel)       Date:  2020-12-21       Impact factor: 4.096

5.  High levels of TDO2 in relation to pro-inflammatory cytokines in synovium and synovial fluid of patients with osteoarthritis.

Authors:  Genxiang Rong; Tao Zhang; Yayun Xu; Zhenyu Zhang; Binjie Gui; Kongzu Hu; Jinling Zhang; Zhi Tang; Cailiang Shen
Journal:  BMC Musculoskelet Disord       Date:  2022-06-22       Impact factor: 2.562

6.  Inhibition of lncRNA NEAT1 induces dysfunction of fibroblast-like synoviocytes in rheumatoid arthritis via miRNA-338-3p-mediated regulation of glutamine metabolism.

Authors:  Mei Zhang; Ning Lu; Hong-Jun Li; Xiao-Yun Guo; Lu Lu; Ying Guo
Journal:  J Orthop Surg Res       Date:  2022-09-01       Impact factor: 2.677

7.  Imperatorin Inhibits Proliferation, Migration, and Inflammation via Blocking the NF-κB and MAPK Pathways in Rheumatoid Fibroblast-like Synoviocytes.

Authors:  Wei Lin; Gang Chen; Yuhang Mao; Xuemei Ma; Junnan Zhou; Xiaolu Yu; Chaoliang Wang; Mei Liu
Journal:  ACS Omega       Date:  2022-08-16

8.  Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis.

Authors:  Li Zheng; Liling Xu; Fanlei Hu; Jimeng Xue; Mingxin Bai; Ranran Yao; Huaqun Zhu; Hua Zhong; Yin Su
Journal:  Clin Exp Immunol       Date:  2022-09-29       Impact factor: 5.732

9.  Myrtenal and β-caryophyllene oxide screened from Liquidambaris Fructus suppress NLRP3 inflammasome components in rheumatoid arthritis.

Authors:  Wen-Xuan Li; Ping Qian; Yi-Tong Guo; Li Gu; Jessore Jurat; Yang Bai; Dong-Fang Zhang
Journal:  BMC Complement Med Ther       Date:  2021-09-28

10.  TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models.

Authors:  Jiao Wu; Zhuan Feng; Liang Chen; Yong Li; Huijie Bian; Jiejie Geng; Zhao-Hui Zheng; Xianghui Fu; Zhuo Pei; Yifei Qin; Liu Yang; Yilin Zhao; Ke Wang; Ruo Chen; Qian He; Gang Nan; Xuejun Jiang; Zhi-Nan Chen; Ping Zhu
Journal:  Nat Commun       Date:  2022-02-03       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.